Your browser doesn't support javascript.
loading
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
Guglieri, Michela; Bushby, Kate; McDermott, Michael P; Hart, Kimberly A; Tawil, Rabi; Martens, William B; Herr, Barbara E; McColl, Elaine; Speed, Chris; Wilkinson, Jennifer; Kirschner, Janbernd; King, Wendy M; Eagle, Michelle; Brown, Mary W; Willis, Tracey; Griggs, Robert C; Straub, Volker; van Ruiten, Henriette; Childs, Anne-Marie; Ciafaloni, Emma; Shieh, Perry B; Spinty, Stefan; Maggi, Lorenzo; Baranello, Giovanni; Butterfield, Russell J; Horrocks, I A; Roper, Helen; Alhaswani, Zoya; Flanigan, Kevin M; Kuntz, Nancy L; Manzur, Adnan; Darras, Basil T; Kang, Peter B; Morrison, Leslie; Krzesniak-Swinarska, Monika; Mah, Jean K; Mongini, Tiziana E; Ricci, Federica; von der Hagen, Maja; Finkel, Richard S; O'Reardon, Kathleen; Wicklund, Matthew; Kumar, Ashutosh; McDonald, Craig M; Han, Jay J; Joyce, Nanette; Henricson, Erik K; Schara-Schmidt, Ulrike; Gangfuss, Andrea; Wilichowski, Ekkehard.
Afiliación
  • Guglieri M; John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, England.
  • Bushby K; John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, England.
  • McDermott MP; Department of Neurology, University of Rochester Medical Center, Rochester, New York.
  • Hart KA; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York.
  • Tawil R; Department of Neurology, University of Rochester Medical Center, Rochester, New York.
  • Martens WB; Department of Neurology, University of Rochester Medical Center, Rochester, New York.
  • Herr BE; Department of Neurology, University of Rochester Medical Center, Rochester, New York.
  • McColl E; Department of Neurology, University of Rochester Medical Center, Rochester, New York.
  • Speed C; Newcastle University, Newcastle upon Tyne, England.
  • Wilkinson J; Newcastle University, Newcastle upon Tyne, England.
  • Kirschner J; NIHR Clinical Research Network North East and North Cumbria, Newcastle upon Tyne, England.
  • King WM; Newcastle University, Newcastle upon Tyne, England.
  • Eagle M; Department of Neuropediatrics and Muscle Disorders, Faculty of Medicine, University Hospital Freiburg, Freiburg, Germany.
  • Brown MW; Department of Neuropediatrics, University Hospital Bonn, Bonn, Germany.
  • Willis T; Ohio State University, Columbus.
  • Griggs RC; John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, England.
  • Straub V; Robert Jones and Agnes Hunt Orthopaedic Hospital, NHS Foundation Trust, Oswestry, England.
  • van Ruiten H; Department of Neurology, University of Rochester Medical Center, Rochester, New York.
  • Ciafaloni E; John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, England.
  • Shieh PB; John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, England.
  • Spinty S; Leeds General Infirmary, Leeds, England.
  • Maggi L; Department of Neurology, University of Rochester Medical Center, Rochester, New York.
  • Baranello G; David Geffen School of Medicine, University of California, Los Angeles.
  • Butterfield RJ; Alderhey Children's Hospital NHS Foundation Trust, Liverpool, England.
  • Horrocks IA; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Roper H; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Alhaswani Z; Dubowitz Neuromuscular Centre, UCL NIHR GOSH Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health, London, England.
  • Flanigan KM; Department of Pediatric Neurology, University of Utah, Salt Lake City.
  • Kuntz NL; Glasgow Paediatric Neuromuscular Research Centre, Greater Glasgow and Clyde NHS Yorkhill Hospital, Glasgow, Scotland.
  • Manzur A; University Hospitals Birmingham NHS Foundation Trust, Birmingham, England.
  • Darras BT; University Hospitals Birmingham NHS Foundation Trust, Birmingham, England.
  • Kang PB; Center for Gene Therapy, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio.
  • Morrison L; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
  • Krzesniak-Swinarska M; Great Ormond Street Hospital, London, England.
  • Mah JK; Department of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Mongini TE; Department of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Ricci F; Paul and Sheila Wellstone Muscular Dystrophy Center and Department of Neurology, University of Minnesota Medical School, Minneapolis.
  • von der Hagen M; Health Sciences Center, University of New Mexico, Albuquerque.
  • Finkel RS; Health Sciences Center, University of New Mexico, Albuquerque.
  • O'Reardon K; Cumming School of Medicine, University of Calgary and Alberta Children's Hospital Research Institute, Calgary, Canada.
  • Wicklund M; Neuromuscular Center, AOU Città della Salute e della Scienza, University of Turin, Turin, Italy.
  • Kumar A; Neuromuscular Center, AOU Città della Salute e della Scienza, University of Turin, Turin, Italy.
  • McDonald CM; Abteilung Neuropädiatrie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Han JJ; Nemours Children's Hospital, Orlando, Florida.
  • Joyce N; Center for Experimental Neurotherapeutics, St Jude Children's Research Hospital, Memphis, Tennessee.
  • Henricson EK; Nemours Children's Hospital, Orlando, Florida.
  • Schara-Schmidt U; Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania.
  • Gangfuss A; Department of Neurology, School of Medicine, University of Colorado, Aurora.
  • Wilichowski E; Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania.
JAMA ; 327(15): 1456-1468, 2022 04 19.
Article en En | MEDLINE | ID: mdl-35381069
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prednisona / Distrofia Muscular de Duchenne / Glucocorticoides Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Child / Child, preschool / Female / Humans / Male Idioma: En Revista: JAMA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prednisona / Distrofia Muscular de Duchenne / Glucocorticoides Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Child / Child, preschool / Female / Humans / Male Idioma: En Revista: JAMA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos